Nuwellis (NUWE) Cash & Equivalents (2011 - 2026)
Nuwellis (NUWE) posted Cash & Equivalents of $2.1 million for Q1 2026, up 91.98% on a QoQ basis from $1.1 million in Q4 2025, and down 18.54% year-over-year from $2.6 million in Q1 2025.
Nuwellis (NUWE) Cash & Equivalents (2011 - 2026) Analysis & Trends
Nuwellis' Cash & Equivalents history runs 16 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- Quarterly Cash & Equivalents fell 18.54% year-over-year to $2.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.1 million (down 18.54% YoY) and the FY2025 annual result came in at $1.1 million, down 78.7% from the prior year.
- Cash & Equivalents was $2.1 million for Q1 2026 at Nuwellis, up from $1.1 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $19.3 million in Q1 2022 and bottomed at $1.0 million in Q2 2024.
- A 5-year average of $6.8 million and a median of $4.4 million in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2024 — Cash & Equivalents tumbled 88.5% — and 2025, when it jumped 335.0%.
- Nuwellis' Cash & Equivalents stood at $17.7 million in 2022, then slumped by 78.58% to $3.8 million in 2023, then jumped by 34.08% to $5.1 million in 2024, then slumped by 78.7% to $1.1 million in 2025, then jumped by 91.98% to $2.1 million in 2026.
- Business Quant data shows NUWE's Cash & Equivalents at $2.1 million in Q1 2026, $1.1 million in Q4 2025, and $3.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Nuwellis | 613.80 | -2.08 Mn | 1.68 Mn | 2.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.08 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 3.09 Mn |
| Jun 30, 2025 | 4.45 Mn |
| Mar 31, 2025 | 2.56 Mn |
| Dec 31, 2024 | 5.10 Mn |
| Sep 30, 2024 | 1.91 Mn |
| Jun 30, 2024 | 1.02 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 3.80 Mn |
| Sep 30, 2023 | 4.93 Mn |
| Jun 30, 2023 | 8.90 Mn |
| Mar 31, 2023 | 11.52 Mn |
| Dec 31, 2022 | 17.74 Mn |
| Sep 30, 2022 | 12.05 Mn |
| Jun 30, 2022 | 15.35 Mn |
| Mar 31, 2022 | 19.30 Mn |
| Dec 31, 2021 | 8.74 Mn |
| Sep 30, 2021 | 28.43 Mn |
| Jun 30, 2021 | 23.98 Mn |